|
| | 101ST GENERAL ASSEMBLY
State of Illinois
2019 and 2020 HB4657 Introduced 2/5/2020, by Rep. Deanne M. Mazzochi SYNOPSIS AS INTRODUCED: |
| 20 ILCS 2310/2310-312.5 new | |
|
Amends the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois Act. Requires the Department of Public Health to identify at least 2 hospitals that have had over the last 5 years similar reported levels of patients with one or more types of hospital-acquired infections and to solicit proposals from at least one such hospital to conduct a pilot program to install in common hospital touch surfaces antimicrobial metallic material in the rooms of patients likely to be at high risk of hospital-acquired infections. Provides that installation costs for the pilot program shall be classified as capital infrastructure improvements and eligible for capital development grants. Contains specified requirements for the Department regarding the pilot program.
|
| |
| | | FISCAL NOTE ACT MAY APPLY | |
| | A BILL FOR |
|
|
| | HB4657 | | LRB101 18988 CPF 68447 b |
|
|
1 | | AN ACT concerning State government.
|
2 | | Be it enacted by the People of the State of Illinois,
|
3 | | represented in the General Assembly:
|
4 | | Section 5. The Department of Public Health Powers and |
5 | | Duties Law of the
Civil Administrative Code of Illinois is |
6 | | amended by adding Section 2310-312.5 as follows: |
7 | | (20 ILCS 2310/2310-312.5 new) |
8 | | Sec. 2310-312.5. Disinfection innovation pilot program. |
9 | | The Department shall identify at least 2 hospitals that have |
10 | | had over the last 5 years similar reported levels of patients |
11 | | with one or more types of hospital-acquired infections, |
12 | | including, but not limited to, Staphylococcal infections, c. |
13 | | difficile, e. coli, P. aeruginosa, and methicillin-resistant |
14 | | Staphylococcus aureus (MRSA). The Department shall solicit |
15 | | proposals from at least one such hospital to conduct a pilot |
16 | | program to install in common hospital touch surfaces (such as |
17 | | patient beds, light switches, and door knobs and plates) |
18 | | antimicrobial metallic material (which may include copper or |
19 | | silver alloy metal wall plates, copper-oxide impregnated hard |
20 | | surfaces, silver or zinc oxides, metallic nanoparticles, or |
21 | | silver-ruthenium complexes) in the rooms of patients likely to |
22 | | be at high risk of hospital-acquired infections. Installation |
23 | | costs for the pilot program shall be classified as capital |